home All News open_in_new Full Article

New Published Data Confirms Nemluvio® (Nemolizumab) Can Rapidly Relieve Itch and Improve Sleep in as Early as Two Days in Both Atopic Dermatitis and Prurigo Nodularis

Post-hoc analyses of the phase III ARCADIA and OLYMPIA clinical trial programs, published in the Journal of the European Academy of Dermatology and Venereology, highlight nemolizumab’s fast onset of action and improvement of itch and sleep disturbance in patients with moderate-to-severe atopic dermatitis and prurigo nodularis1 Significant improvements in itch were observed as early as […]


today 9 h. ago attach_file Economics

attach_file Economics
attach_file Other
attach_file Society
attach_file Economics
attach_file Economics
attach_file Other
attach_file Society
attach_file Other
attach_file Sport
attach_file Society
attach_file Economics
attach_file Economics
attach_file Politics
attach_file Society
attach_file Economics
attach_file Economics
attach_file Society
attach_file Other
attach_file Other
attach_file Economics


ID: 1519018463
Add Watch Country

arrow_drop_down